M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations... Show more
MTHRY broke above its upper Bollinger Band on January 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 39 similar instances where the stock broke above the upper band. In of the 39 cases the stock fell afterwards. This puts the odds of success at .
The Momentum Indicator moved below the 0 level on January 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MTHRY as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for MTHRY turned negative on January 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTHRY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MTHRY's RSI Indicator exited the oversold zone, of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where MTHRY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MTHRY advanced for three days, in of 269 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 128 cases where MTHRY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.355) is normal, around the industry mean (19.502). P/E Ratio (28.364) is within average values for comparable stocks, (99.648). MTHRY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.997). Dividend Yield (0.012) settles around the average of (0.030) among similar stocks. P/S Ratio (3.934) is also within normal values, averaging (64.610).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MTHRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTHRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
Industry ServicestotheHealthIndustry
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DVYE | 34.39 | 0.41 | +1.21% |
| iShares Emerging Markets Dividend ETF | |||
| TCPB | 51.27 | 0.03 | +0.05% |
| Thrivent Core Plus Bond ETF | |||
| NXTI | 31.62 | N/A | N/A |
| Simplify Next Intangible Core Index ETF | |||
| BSJU | 26.12 | -0.03 | -0.11% |
| Invesco BulletShares 2030 HY Corp Bd ETF | |||
| EWUS | 44.04 | -0.31 | -0.69% |
| iShares MSCI United Kingdom Small-Cp ETF | |||
A.I.dvisor indicates that over the last year, MTHRY has been loosely correlated with DASTY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MTHRY jumps, then DASTY could also see price increases.
| Ticker / NAME | Correlation To MTHRY | 1D Price Change % | ||
|---|---|---|---|---|
| MTHRY | 100% | +1.82% | ||
| DASTY - MTHRY | 37% Loosely correlated | -0.40% | ||
| FFIV - MTHRY | 29% Poorly correlated | +1.85% | ||
| TEAM - MTHRY | 26% Poorly correlated | -3.79% | ||
| CCOEY - MTHRY | 26% Poorly correlated | -1.49% | ||
| UBSFY - MTHRY | 26% Poorly correlated | -4.71% | ||
More | ||||
| Ticker / NAME | Correlation To MTHRY | 1D Price Change % |
|---|---|---|
| MTHRY | 100% | +1.82% |
| Health Services category (410 stocks) | -0% Poorly correlated | -0.91% |
| Services to the Health Industry category (92 stocks) | -0% Poorly correlated | -3.52% |